Queen Mary University of London
London, E1 2AB, United Kingdom
NCT Number: NCT04695093
Investigating the impact of London's Ultra Low Emission Zone on children's respiratory health
Looking for future studies?
Notify Me9 year–9 year
All sexes
Observational
London, E1 2AB, United Kingdom
Strong evidence links urban air pollution to restrictions in children's lung growth and development and other adverse effects, including increases in respiratory and allergy symptoms, respiratory infections, asthma, and health care use. Effective interventions are urgently needed that reduce air pollution and improve child health. Low Emission Zones (LEZ) are becoming widespread but are expensive to implement and of unproven health benefit. London has some of the worst air pollution in Europe. London's Ultra Low Emission Zone (ULEZ) is the central component of London's air quality strategy. Its implementation provides a unique opportunity to test the impact of a city-wide LEZ on children's health.
The intervention:
The ULEZ is an area within which all vehicles must meet exhaust emission standards or pay a daily charge to travel. It will be implemented and paid for by Transport for London. Starting in 2019, the ULEZ will initially cover London's central Congestion Charging Zone, an area bounded by the London Inner Ring Road, that includes the City of London plus adjacent areas of eight radially adjoining Boroughs. It is projected to deliver for central London by 2020 emission reductions of -49% for NOx; - 47% for NO2; and -11% for PM10. Subject to consultation, the ULEZ will subsequently extend to include an inner London area (within London's North and South Circular roads), and a London-wide area, for heavy vehicles only.
Questions:
Study design:
Quasi-experimental study using a parallel cohort design. Population: 1520 children aged 6-9 yrs old, recruited in 26 London primary schools (school years 2, 3 and 4) in London's Central Ultra Low Emission Zone. Intervention: Ultra Low Emission Zone Comparison: 1520 children aged 6-9 yrs old, recruited in 26 primary schools (school years 2, 3 and 4) in Luton, matched for ethnicity, deprivation and baseline air quality.
Outcome: PRIMARY: Lung function growth (post-bronchodilator forced expiratory volume in one second (FEV1) measured by high quality spirometry at sequential annual school visits over four years. SECONDARY: Forced vital capacity (FVC), exhaled nitric oxide (FeNO), quality of life, respiratory infections, health care use, health costs.
Sample size:
To detect a 15ml/year FEV1 difference between central and outer London cohorts at 90% power and 0.05 significance requires children in each cohort, inflated to allow for clustering effect of schools, spirometry success, child and school attrition, and pre-specified sub group analyses, giving a total of 3120 children (60 children from 26 schools in each cohort).
Duration: 6 years Air quality data: Modeled exposures by London Air Quality Network Data management: NIHR accredited Pragmatic Clinical Trials Unit Analysis: Interaction analysis controlling for effect modifiers (eg passive smoke; ethnicity); health economic cost consequence analysis.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Inclusion criteria
for children:
Exclusion criteria
Exclusion criteria
for children:
The ULEZ comprises a Central London zone, implemented on 8th April 2019, within which polluting vehicles are subject to a charge. Using number plate recognition technology, a daily penalty charge notice is issued for vehicles entering this central zone not meeting the standard of Euro 4 for petrol, Euro 6/VI for diesel, and Euro for motorcycles.
The ULEZ will subsequently be extended to include:
Other names: Clean Air Zone
Time frame: Four years, 2018 -2021
Measured by annual spirometry, as annual change in FEV1/year over 4 years
Time frame: Four years, 2018 -2021
Annual nitrogen dioxide (NO2) concentration (micrograms/cubic meter NO2)
Time frame: Four years, 2018 -2021
Annual oxides of nitrogen (NOx) concentration (micrograms/cubic meter NOx)
Time frame: Four years, 2018 -2021
Annual particulate matter diameter <2.5microns (PM2.5) concentration (micrograms/cubic meter PM2.5)
Time frame: Four years, 2018 -2021
Annual particulate matter diameter <2.5microns (PM2.5) concentration (micrograms/cubic meter PM10)
Time frame: Four years, 2018 -2021
Measured by annual spirometry, as FVC in litres
Time frame: Four years, 2018 -2021
International Study of Asthma and Allergies in Childhood (ISAAC) questionnaire for 6-7 year olds
Time frame: Four years, 2018 -2021
International Study of Asthma and Allergies in Childhood (ISAAC) questionnaire for 6-7 year olds
Time frame: Four years, 2018 -2021
International Study of Asthma and Allergies in Childhood (ISAAC) questionnaire for 6-7 year olds
Time frame: Four years, 2018 -2021
Electronic download of coded NHS health record data
Time frame: Four years, 2018 -2021
Electronic download of coded NHS health record data
Time frame: Four years, 2018 -2021
Annual hip accelerometer records of participants, measured over one week
Time frame: Four years, 2018 -2021
Electronic download of coded NHS health record data
Time frame: Four years, 2018 -2021
Electronic download of coded NHS health record data and self report data
Time frame: Three years, 2019 -2021
Annual Clinical Kinematic Assessment Test
Time frame: Four years, 2018 -2021
Annual parental completion of the CHU9D (Child Health Utility 9 Dimension) questionnaire
Queen Mary University of London
Other
Investigating the Impact of London's Ultra Low Emission Zone on Children's Respiratory Health
Acronym: CHILL
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04068389
Female Urogenital Diseases and Pregnancy Complications, Lung; Premature
View Trial DetailsNCT06386055
Behavior, Physical Inactivity
Buffalo, New York, United States
View Trial DetailsNCT07229131
Pollution; Exposure
Guangzhou, China
View Trial DetailsNCT06588530
Actinomycetales Infections, Adult
Paulsboro, New Jersey, United States
View Trial Details